✦ LIBER ✦

Cyclopropane-Based Conformational Restriction of Histamine. (1 S ,2 S )-2-(2-Aminoethyl)-1-(1 H -imidazol-4-yl)cyclopropane, a Highly Selective Agonist for the Histamine H 3 Receptor, Having a cis -Cyclopropane Structure

✍ Scribed by Kazuta, Yuji; Hirano, Kazufumi; Natsume, Kentaro; Yamada, Shizuo; Kimura, Ryohei; Matsumoto, Shun-ichiro; Furuichi, Kiyoshi; Matsuda, Akira; Shuto, Satoshi

Book ID: 120368734
Publisher: American Chemical Society
Year: 2003
Tongue: English
Weight: 136 KB
Volume: 46
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm020415q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of Versatile cis - and trans

Development of Versatile cis - and trans -Dicarbon-Substituted Chiral Cyclopropane Units: Synthesis of (1 S ,2 R )- and (1 R ,2 R )-2-Aminomethyl-1-(1 H -imidazol-4-yl)cyclopropanes and Their Enantiomers as Conformationally Restricted Analogues of Histamine

✍ Kazuta, Yuji; Matsuda, Akira; Shuto, Satoshi 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 134 KB

Discovery and Characterization of 6-{4-[

Discovery and Characterization of 6-{4-[3-( R )-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2 H -pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H 3 Receptor Inverse Agonist

✍ Hudkins, Robert L.; Raddatz, Rita; Tao, Ming; Mathiasen, Joanne R.; Aimone, Lisa 📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 1007 KB

Discovery of N-benzyl-2-[(4S)-4-(1H-indo

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

✍ Richard L. Elliott; Kimberly O. Cameron; Janice E. Chin; Jeremy A. Bartlett; Ele 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 598 KB

We describe the design, synthesis, and structure-activity relationships of triazolobenzodiazepinone CCK1 receptor agonists. Analogs in this series demonstrate potent agonist activity as measured by in vitro and in vivo assays for CCK1 agonism. Our efforts resulted in the identification of compound 4

Discovery and Structure−Activity Relatio

Discovery and Structure−Activity Relationship of 3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): A Highly Selective 5-Hydroxytryptamine2A Receptor Inverse Agonist for the Treatment of Arterial Thrombosis

✍ Xiong, Yifeng; Teegarden, Bradley R.; Choi, Jin-Sun Karoline; Strah-Pleynet, Son 📂 Article 📅 2010 🏛 American Chemical Society 🌐 English ⚖ 887 KB

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views